243 related articles for article (PubMed ID: 25563643)
1. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
[TBL] [Abstract][Full Text] [Related]
2. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.
di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
Eur J Epidemiol; 2015 Feb; 30(2):131-41. PubMed ID: 25527370
[TBL] [Abstract][Full Text] [Related]
4. Association of FGF23 with Incident Sepsis in Community-Dwelling Adults: A Cohort Study.
Paul S; Judd SE; Wang HE; Gutiérrez OM
Kidney360; 2020 Sep; 1(9):950-956. PubMed ID: 35369560
[TBL] [Abstract][Full Text] [Related]
5. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
Wright CB; Dong C; Stark M; Silverberg S; Rundek T; Elkind MS; Sacco RL; Mendez A; Wolf M
Neurology; 2014 May; 82(19):1700-6. PubMed ID: 24706015
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study.
Panwar B; Judd SE; Howard VJ; Jenny NS; Wadley VG; Gutiérrez OM
PLoS One; 2016; 11(11):e0165671. PubMed ID: 27812184
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
[TBL] [Abstract][Full Text] [Related]
9. FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study.
Akhabue E; Montag S; Reis JP; Pool LR; Mehta R; Yancy CW; Zhao L; Wolf M; Gutierrez OM; Carnethon MR; Isakova T
Hypertension; 2018 Jul; 72(1):70-76. PubMed ID: 29712737
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.
Garimella PS; Ix JH; Katz R; Chonchol MB; Kestenbaum BR; de Boer IH; Siscovick DS; Shastri S; Hiramoto JS; Shlipak MG; Sarnak MJ
Atherosclerosis; 2014 Mar; 233(1):91-6. PubMed ID: 24529128
[TBL] [Abstract][Full Text] [Related]
12. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.
Akhabue E; Vu TT; Vaidya A; Michos ED; de Boer IH; Kestenbaum B; Allison M; Szklo M; Ouyang P; Yancy CW; Wolf M; Isakova T; Carnethon MR
Am J Hypertens; 2019 Jan; 32(1):18-25. PubMed ID: 30256890
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
Ishigami J; Jaar BG; Rebholz CM; Grams ME; Michos ED; Wolf M; Kovesdy CP; Uchida S; Coresh J; Lutsey PL; Matsushita K
J Clin Endocrinol Metab; 2017 Dec; 102(12):4648-4657. PubMed ID: 29029099
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and incident stroke risk in community-living black and white adults.
Judd SE; Morgan CJ; Panwar B; Howard VJ; Wadley VG; Jenny NS; Kissela BM; Gutiérrez OM
Int J Stroke; 2016 Jan; 11(1):93-102. PubMed ID: 26763025
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
Westerberg PA; Tivesten Å; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Larsson TE; Linde T; Ljunggren Ö
BMC Nephrol; 2013 Apr; 14():85. PubMed ID: 23587028
[TBL] [Abstract][Full Text] [Related]
18. Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
Lane NE; Parimi N; Corr M; Yao W; Cauley JA; Nielson CM; Ix JH; Kado D; Orwoll E;
J Bone Miner Res; 2013 Nov; 28(11):2325-32. PubMed ID: 23677793
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults.
Nowak KL; Bartz TM; Dalrymple L; de Boer IH; Kestenbaum B; Shlipak MG; Garimella PS; Ix JH; Chonchol M
J Am Soc Nephrol; 2017 Apr; 28(4):1239-1246. PubMed ID: 28122946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
